Uso de pregn-4-en-20-in-3-ona para el tratamiento de trastornos depresivos
- 专利权人:
- Pherin Pharmaceuticals; Inc.
- 发明人:
- MONTI, Louis
- 申请号：
- ES13819136
- 公开号：
- ES2625778T3
- 申请日:
- 2013.12.19
- 申请国别(地区):
- ES
- 年份:
- 2017
- 代理人:
- 摘要：
- Pregn-4-en-20-yn-3-one for use in the treatment of nasal an individual suffering from a depressive disorder.Pregn-4-en-20-in-3-ona para su uso en el tratamiento por vía nasal de un individuo que padece un trastorno depresivo.孕烷-4-En-20YN-3-One用于治疗患有抑郁症的鼻部患者。
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- "method for treating a patient suffering from metabolic disorder, method for treating at least one non-metabolic disorder in a patient, method for treating at least one metabolic disorder and at least one non-metabolic disorder in a patient method for treating at least one vascular disease in a patient and effective pharmaceutical composition for the treatment of metabolic syndrome, type 2 diabetes, obesity, or pre-diabetes "
- methods of predicting the reaction of patients suffering from an inflammatory disorder, predicting the ability of patients to react, identifying patients suffering from an inflammatory disorder and its treatment, use of kits and kits
- METHOD FOR TREATING DEPRESSION AND MAJOR DEPRESSIVE DISORDER
- METHOD FOR TREATING DEPRESSION AND MAJOR DEPRESSIVE DISORDER
- MGLU2 AGONISTS
